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Abstract
Rheumatoid arthritis is the most common inflammatory arthritis, affecting approximately 
1% of the world’s population. Its pathogenesis has not been completely understood. However, 
there is evidence that the disease may involve synovial joints, subchondral bone marrow 
as well as intra- and extraarticular fat tissue, and may lead to progressive joint destruction 
and disability. Over the last two decades, significant improvement in its prognosis has been 
achieved owing to new strategies for disease management, the emergence of new biologic 
therapies and better utilization of conventional disease-modifying antirheumatic drugs. 
Prompt diagnosis and appropriate therapy have been recognized as essential for improv-
ing clinical outcomes in patients with early rheumatoid arthritis. Despite the potential of 
ultrasonography and magnetic resonance imaging to visualize all tissues typically involved 
in the pathogenesis of rheumatoid arthritis, the diagnosis of early disease remains difficult 
due to limited specificity of findings. This paper summarizes the pathogenesis phenomena 
of rheumatoid arthritis and describes rheumatoid arthritis-related features of the disease 
within the synovium, subchondral bone marrow and articular fat tissue on MRI and ul-
trasound. Moreover, the paper aims to illustrate the significance of MRI and ultrasound 
findings in rheumatoid arthritis in the diagnosis of subclinical and early inflammation, and 
the importance of MRI and US in the follow-up and establishing remission. Finally, we also 
discuss MRI of the spine in rheumatoid arthritis, which may help assess the presence of ac-
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Introduction 
Rheumatoid arthritis (RA) is the most common inflamma-
tory arthritis, affecting approximately 1% of the world’s 
population(1). It is characterized by proliferative, hyper-
vascularized synovitis and osteitis, resulting in bone ero-
sion, cartilage damage, joint destruction and long-term 
disability(2). Over the last two decades, significant im-
provement in its prognosis has been achieved owing to 
new strategies for disease management, the emergence of 
new biologic therapies and better utilization of conven-
tional disease-modifying antirheumatic drugs(1). Prompt 
diagnosis and appropriate therapy have been recognized 
as essential for improving clinical outcomes in patients 
with early RA(1).
Diagnosis of RA is based on clinical, laboratory and radio-
graphic findings.
Conventional radiography has been the imaging modality 
of choice in RA primarily because of its reproducibility and 
feasibility with respect to detecting structural damage(1–3). 
However, radiography can provide only indirect informa-
tion on synovial inflammation, and the technique is insen-
sitive to early inflammatory bone involvement and bone 
damage(2). 
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Until recently, the absence of effective treatment to prevent 
joint destruction has limited the need for more sensitive 
imaging techniques. This situation changed after the de-
velopment of new therapeutics for RA, such as anti-tumor 
necrosis factor (TNF) agents(2). The availability of these 
potent and expensive drugs has created new demands for 
radiologists to identify patients with aggressive RA at an 
early stage(2).
Magnetic resonance imaging (MRI) and ultrasonog-
raphy (US) are increasingly being used in the assess-
ment of RA in research and clinical practice due to 
their capacity to provide insight into the pathogenesis 
of inflammatory joint disease and ability to identify 
the key pathologic features of this disease entity at 
presentation, much earlier than they are seen on ra-
diography(2,3). Both modalities are characterized by 
high sensitivity in depicting local inflammation in the 
form of synovitis, tenosynovitis and bursitis, which is 
greater than in clinical examination and conventional 
radiography and can help establish an early diagnosis 
in RA(3). 
MRI also allows the detection of bone marrow ede-
ma, which is thought to be a precursor for the devel-
opment of erosions in early RA as well as a marker 
of active inflammation(1), and can be seen neither on 
radiographs,ultrasound or CT. In addition, the multi-
plane, multislice capability of MRI allows visualiza-
tion of the area of interest in three orthogonal planes. 
Therefore, MRI has the advantage of providing details 
concerning both the bone and surrounding tissues of the 
joint, which is not shared by any other imaging modality, 
whilst avoiding ionizing radiation(3). 
In particular, MRI in RA allows(4): 
• assessment of peripheral joints for active inflammation 
in the form of joint effusions, synovitis, tenosynovitis, 
BME, as well as subsequent structural lesions, such as 
articular cartilage damage, cortical bone erosions, and 
tendons tears; 
• assessment of inflammatory changes and post-inflam-
matory complications in the spine, i.e. assessment of 
inflammatory activity, atlanto-axial / atlanto-occipital 
structural lesions (e.g. subluxations);
• qualitative, semi-quantitative and quantitative measure-
ments in dynamic contrast-enhanced MRI (DCE-MRI) of 
active inflammation. 
Advantages of ultrasound include:
• high availability, low cost, and high patient acceptance 
compared to MRI;
• assessment of peripheral joints for active inflammation 
in the form of effusion, synovitis, tenosynovitis, as well 
as subsequent structural lesions, such as tendons tears, 
whereas cortical bone erosions and articular cartilage 
damage can be seen to some extent;
• dynamic examination of peripheral joints, useful in 
the assessment of inflammatory changes, e.g., im-
pingement of the inflamed subacromial bursa with 
acromion, stability of the ulnar nerve, tendon sublux-
ations and luxations (e.g. extensor carpi ulnaris ten-
don), tendons tears;
• qualitative, semi-quantitative and quantitative measure-
ments of inflammation (intensity of vascularization, 
thickness of synovium).
Pathogenesis of RA and RA-related 
pathological phenomena within the synovium, 
subchondral bone marrow and articular fat 
tissue in MRI and ultrasound
The pathogenesis of RA has been understood to some 
extent only. However, there is evidence that the process 
of joint destruction is initiated in the joint cavity and 
bone marrow. In addition, adipose tissue may also play 
a pro-inflammatory and pro-destructive role. So far, it 
has not been determined what triggers the formation of 
inflammatory infiltrates in the synovial membrane. En-
vironmental factors, such as cigarette smoking and por-
phyromonas gingivalis, are thought to play a role. In cer-
tain predisposed individuals, the synovium may thicken 
rapidly within a few months due to hyperplasia, which 
is an increase in the number of fibroblast-like synovio-
cytes from 1–3 layers to up to 12 layers. The subintima 
layer, which in healthy individuals is composed of loose 
connective tissue with blood and lymphatic vessels, nerve 
fibers and several cell types, may thicken as a result of 
edema caused by migration and retention of infiltrating 
cells. This thickened synovium is well-visible on US and 
MRI scans(4–7). 
The thickened synovium is also characterized by in-
creased vascularity, which is a result of angiogenesis. 
This aspect of the disease is also well-visible on both 
Doppler ultrasonography and MRI on contrast-en-
hanced T1-weighted images. DCE-MRI shows increased 
permeability of neovessels(8).
If RA is recognized early and aggressive treatment is in-
troduced early on (i.e. within the first 3 months, known 
as a therapeutic window), it is possible to suppress the 
inflammatory reaction. Otherwise, the disease could 
take on a more chronic, aggressive form, with joint de-
struction. 
RA does not only involve the synovium. MRI showed that 
the inflammatory process also takes place within the bone, 
and that BME reflects inflammatory infiltration in the 
bone marrow in RA(1,9). When untreated, BME leads to the 
development of erosions(10–12).
The third compartment with the inflammatory and de-
structive potential in RA is the adipose tissue. The adipose 
tissue is infiltrated by immune cells and produces over 50 
adipocytokines or adipokines as well as other inflammato-
ry mediators and factors which are secreted into the joint 
fluid and may influence the metabolism of the cartilage 
and synovial membrane as well as sustain the inflamma-
tory response(13).
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RA-related pathological phenomena within 
the synovium, subchondral bone marrow, 
and peri-articular fat tissue on MRI and 
ultrasound
Abnormalities in early RA include synovitis, tenosynovitis, 
bursitis, BME and adipose tissue inflammation. On MR 
and US images, early RA-related pathologies include thick-
ening of the synovium of the joint capsule, tendon sheaths 
and bursae. In the next stage of the disease, vasculariza-
tion of the synovium, resulting from neo-angiogenesis, is 
observed. Joint effusion is seen early in the disease process 
in RA and is commonly associated with synovitis, tenosy-
novitis and bursitis. BME accompanies synovitis in the 
majority of patients. However, it could be the only area 
involved in early RA.
Synovitis 
Proliferative synovitis (rheumatoid pannus) is the earliest 
pathologic abnormality in rheumatoid arthritis, and it is 
secondarily responsible for bone and cartilage damage(2). 
It involves peripheral joints, most frequently of the hand 
and wrist, ankle and foot and cervical spine. In the hand, 
wrist, ankle and foot it is usually, but not exclusively, bilat-
eral. With the disease progression, neovessels will be seen 
within the thickened (first hyperplastic and then hypertro-
phied) synovium.
MRI reveals proliferative synovitis as thickening of the 
synovial membrane, which has intermediate to low 
signal intensity on T1-weighted images and, due to in-
creased water content of synovitis, high signal intensity 
on T2-, PD-weighted and STIR/TIRM images(1). Con-
trast-enhanced T1-weighted images are more sensitive 
and specific in the assessment of acute synovitis than 
non-contrast MRI(1). On post-contrast images, the in-
flamed synovium shows fast enhancement, which lasts 
approximately 5 minutes after injection(1,2) (Fig. 1). 
The delay between contrast administration and scan-
ning is important as the volume of enhancing synovitis 
increases initially before stabilizing after about 4 min. 
After 6–11 minutes, contrast reaches the synovial fluid, 
obscuring the synovium / fluid interface(1,13,14). Imaging 
is then best performed between these times. Images 
obtained more than 10 minutes after contrast injec-
tion may not accurately delineate the extent of synovi-
tis since gadolinium may diffuse into the synovial joint 
fluid(1). This diffusion may blur the margins of the in-
flamed synovium, which can lead to overestimation of 
synovial volume(1). The use of fat-suppressed gadolini-
um-enhanced T1-weighted images increases the contrast 
between the inflamed synovium and adjacent structures 
on T1 FS (fat saturated) sequences following contrast 
administration(1,2). 
Sonography shows abnormal thickened and hypoechoic 
(relative to subdermal fat) intraarticular tissue that is poor-
ly compressible and that exhibits Doppler signal with color 
or power Doppler imaging(2) (Fig. 2).
Joint effusion occurs early in RA and is commonly asso-
ciated with synovitis. In some patients, it is the first sign 
of inflammation, even if the thickness and signal of the 
synovium are normal or only slightly increased. 
Fig. 1.  MRI, T1 TSE (time spin echo) FS (fat saturation) CM (contrast medium), 
A. axial plane; B. coronal plane: synovitis, erosions and inflammatory 
cysts in the radio-carpal, midcarpal, carpo-metacarpal and metacarpo-
phalangeal joints
A B
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On MR images, this fluid shows high signal intensity on T2-
weighted and PD MR images, it is hypointense on T1-weight-
ed images and has a low signal intensity on fat-suppressed 
gadolinium-enhanced T1-weighted MR images(2). On un-
enhanced MR images, synovitis and joint fluid are usually 
difficult to differentiate. However, heavily T2-weighted im-
ages (TE >140 msec) can be helpful in identifying synovitis, 
which has lower signal intensity than joint effusion(1).
On sonography, the fluid appears anechoic, with no evi-
dence of flow on Doppler imaging, and can be displaced 
from the region by compression with the transducer(2).
Tenosynovitis
Tenosynovitis predominates over joint synovitis in some pa-
tients(1), or can even be the only pathological finding in RA. 
Tenosynovitis in RA is usually bilateral. Although any ten-
don may be affected, at the wrist level the extensor tendon 
sheaths from I to VI compartments are more frequently in-
volved than flexors. At the ankle level, the tibialis posterior, 
flexor digitorum longus, flexor hallucis longus tendons and 
peroneal tendons are more frequently involved than exten-
sors. At the hand and foot level, only flexor tendon sheaths 
are involved as extensors do not have tendon sheaths at 
these levels. Some amount of fluid may be associated with 
tenosynovitis with imaging features identical as in case of 
joint effusion. 
MRI features of inflamed synovium of tendon sheaths are 
the same as in joint space synovitis, and the use of FS T1-
weighted MR imaging is recommended to delineate the 
extent of inflammatory changes in tendon sheaths more 
accurately(1). MRI reveals thickening of the synovial sheath 
with marked enhancement on fat-suppressed gadolinium-
enhanced T1-weighted images(2) (Fig. 3). 
Sonography shows hypoechoic and thickened synovial sheath 
with or without hyperemia on Doppler imaging(2) (Fig. 4). 
In less favorable conditions, inflammation will be seen also 
in tendons (tendonitis secondary to tenosynovitis), which – 
if not treated – may lead to tendon rupture related both to 
invasion of the tendon by the tendon sheath synovitis and 
frying of the tendon against eroded bone margins(1). Inflam-
matory changes representing tendonitis show increased and 
usually heterogeneous signal intensity on both T1- and T2-
weighted MR images(1). On ultrasound, inflamed tendons 
are focally thickened, of low echogenicity and show vessels 
of inflammatory and reparative process. Thickening, thin-
ning, intratendinous tearing or complete discontinuity of 
tendons on MR and ultrasound imaging are all indicative of 
partial or complete tear(1).
Bursitis
Bursitis is not a common finding in patients with early 
rheumatoid arthritis as synovitis and tenosynovitis. In 
hands, it is rarely seen between the extensor tendons and 
metacarpal heads, between the first and second compart-
ment of extensors. In feet, there is intermetatarsal and 
submetatarsal bursitis (located between or beneath the 
metatarsal heads). Other locations include: Achilles ten-
don bursitis, subacromial bursitis, olecranon bursitis and 
gluteus maximus bursitis. 
The signal from inflamed synovium of bursae is identical 
compared to joint space synovitis or tenosynovitis, thus 
showing significant enhancement on MRI after IV gado-
linium injection due to inflammation (Fig. 5). 
On sonography, inflamed bursae may contain exudate 
only or in more chronic cases exudate with fibrotic septa. 
In RA-typical cases, they show thickened hypertrophied 
synovium with exudate. Hyperemia of the synovial lining 
can be seen on Doppler sonography. Secondary involve-
ment of tendons in the case of Achilles tendon bursitis or 
subacromial bursitis is a common complication, as well 
as heel bone erosions in chronic achillobursitis. Moreover, 
Fig. 2.  Ultrasound: synovitis in the PIP (proximal interphalangeal) 2 joint
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ruptured semimembranous-gastrocnemius bursa of the 
popliteal fossa is easily diagnosed on ultrasound (Fig. 6). 
Bone marrow edema (BME)
The ability to image BME is an advantage of MRI over 
ultrasound and radiography(15). BME is seen as hyperin-
tense T2 signal area within trabecular bone with ill-de-
fined margins and signal characteristics consistent with 
increased water content, i.e. high signal on PD FS/SPAIR, 
T2 FS/SPAIR, STIR/TIRM images, and increased signal 
intensity after the administration of gadolinium-based 
contrast material(2,14). With T1-weighted sequences, BME 
has low signal intensity, but changes are less conspicuous 
compared to other pulse sequences(2,14). In early RA, BME 
is usually located in the subchondral bone. However, 
in e.g. carpal bones, it may involve a great proportion 
of bone at some distance from the subchondral bone(1) 
(Fig. 7). Intraosseous cysts are similar to BME in terms 
of signal characteristics, but are better delineated com-
pared to ill-defined areas of BME. From the pathologi-
cal point of view, they represent areas of damaged bone. 
This makes them visible on plain radiography, contrary to 
BME which is not seen. 
Synovitis, tenosynovitis and bursitis can be assessed with 
qualitative, semi-quantitative and quantitative methods. 
As for quantitative methods, inflammatory activity can be 
estimated by quantifying an increase in signal intensity at 
DCE-MRI within inflamed tissues(1,13,15) (Fig. 8). DCE-MRI 
consists in imaging of the same slices at intervals of sev-
eral seconds after iv contrast administration for a period 
of 2–5 min. Absolute and relative early enhancement rate 
(RER) of the synovium can be obtained from the analysis, 
reflecting synovial perfusion and permeability of capillary 
vessels within the inflamed tissue. This is correlated with 
the degree of synovial vascularization which may be useful 
in treatment monitoring(4). 
On ultrasound, CFR (color flow ratio) can be calculated 
after introducing the ROI to the most representative area 
of high vascularization (Fig. 9) 
Adipose tissue inflammation
On MRI, increased signal on T2-weighted images and en-
hancement on post-contrast images of the intra- or extra-
capsular fat tissue may be seen. 
On ultrasound, inflamed fat tissue is of high echogenici-
ty. Additionally, some individuals present vascularization 
(Fig. 10). 
Erosions
The clinical relevance of synovitis and BME in terms 
of their role as erosion precursors is well-studied(3). It 
has been shown that initial erosions are marginal, re-
sult from destructive activity of the synovial pannus 
and are well-seen on plain radiography, ultrasound and 
Fig. 4.  Ultrasound, longitudinal view of tenosynovitis of the extensor carpi ulnaris tendon
Fig. 3.  MRI, T1 TSE FS CM, axial plane: midcarpal joint synovitis, 
tenosynovitis of the flexors and 4th compartment of extensor 
tendons
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MRI (however, the first two methods show only some 
erosions due to the summation on radiographs and lim-
ited access to some articular areas on ultrasound). With 
RA progression, the invasion of the pannus on the joint 
hyaline cartilage and its subsequent damage is seen as 
subchondral bone erosion formation. Joint space nar-
rowing is a radiographic sign cartilage damage. MRI al-
lows direct visualization of joint cartilage. The cartilage 
of even small joints can be depicted on MRI but requires 
high-end equipment and the acquisition of pulse and 
high-resolution sequences. However, cartilage assess-
ment is not included in the current recommendations 
for RA joint assessment(16). Bone destruction also occurs 
in the course of inflammation of the subchondral bone 
marrow, which may cause subcortical bone destruction. 
It is initially seen on radiographs and ultrasound as in-
flammatory cysts and later as erosions. 
On MRI, erosions are sharply marginated trabecular 
bone defects with disrupted cortical bone continuity. 
They are seen in at least 2 planes with low signal inten-
sity on T1-weighted images, high signal intensity on T2-
weighted and STIR images and may show enhancement 
after administration of gadolinium-based contrast ma-
terial, especially well-seen with thin-partition 3D gra-
dient-echo sequences(1,2,4). Erosions may be difficult to 
differentiate from focal regions of BME, although they 
tend to have clearly defined margins and clear cortical 
break(1) (Fig. 11).
On sonography, bone erosions are seen as intraarticular 
discontinuities of the bone surface that are visible in two 
perpendicular planes(2). High signal on Doppler imaging 
suggests the presence of hypervascularized pannus tissue 
in the erosion(2) (Fig. 12). Compared with MRI, sonogra-
phy cannot visualize all erosions because of limitations 
of probe positioning and restricted access to all cartilage 
surfaces. 
The significance of MRI and ultrasound 
findings in rheumatoid arthritis 
According to ESSR(4) and EULAR recommendations, MRI 
is currently considered the best, non-invasive, observer-
independent imaging modality to evaluate inflammation 
of joints, tendons, entheses and bone marrow. The main 
indications for MRI in patients with RA include:
• assessing inflammatory lesions that are not detected on 
clinical examination;
• assessing early signs of inflammation (synovitis, tenosy-
novitis, bursitis, BME) and establishing prognosis (syno-
vitis and bone marrow edema in particular are risk fac-
tors for the progression to structural changes);
• assessing treatment response / monitoring disease activ-
ity and progression;
• assessing remission;
• identification of disease complications.
Ultrasound is commonly performed to evaluate peripheral 
joints, tendons sheaths and bursae in RA due to its availability 
and lower cost. The main indications for ultrasound include:
• assessment of inflammatory lesions that are not detected 
on clinical examination;
• assessment of early signs of inflammation (synovitis, te-
nosynovitis, bursitis);
• assessment of treatment response / monitoring disease 
activity and progression;
• assessment of remission;
• identification of disease complications in peripheral 
joints.
Subclinical inflammation
RA has a period of preclinical disease, and MRI and US 
appear valuable in identifying joints and tendon sheaths 
Fig. 5. Subacromial bursitis in MRI, T1 TSE FS CM
Fig. 6.  Ultrasound: gastrocnemius-semimembranous bursitis
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with subclinical inflammation (synovitis, tenosynovitis, 
bursitis, BME) despite normal physical examination (no 
edema, no pain). This has clinical implications since im-
aging can help confirm subclinical RA. It also has a prog-
nostic value for the subsequent appearance of erosions 
during follow-up(1). 
In a study by van Steenbergen(17), MRI diagnosed subclini-
cal inflammation in 44% of patients clinically suspected 
to progress to RA (non-swollen, non-painful joints, only 
artralgia). 35% of them progressed to clinically evident 
inflammation within 4 months. Krabben et al.(18) found 
subclinical inflammation (BME, synovitis, tenosynovitis) 
in 26% of asymptomatic joints. Radiographic progres-
sion was observed in 4% of those joints within 1 year, in 
comparison to 1% progression of asymptomatic joints and 
without abnormalities in MRI. Inflammation seen on MRI 
was therefore a prognostic factor of progression. 
Early diagnosis
The clinical impact of MRI and US in early diagnosis of RA 
needs to be determined(4). 
Although imaging is not a mandatory part of the current 
American College of Rheumatology ACR/EULAR clas-
sification criteria for RA, MRI and ultrasonography can 
be used to count involved joints in the case of diagnostic 
uncertainty(4). In the joint involvement domain, which can 
provide up to 5 of the 6 required points for an RA diagnosis, 
MRI and US can be used to determine joint involvement(4). 
Also, these modalities can help to differentiate patients 
with aggressive disease in early RA, allowing the targeting 
of expensive therapies to those with a poor prognosis(16). 
On the other hand, however, early inflammatory features, 
such as synovitis, tenosynovitis, bursitis or exudate, could 
be nonspecific, and we are unable to differentiate early 
inflammation from overuse, early osteoarthritis or other 
connective tissue. This also concerns BME, which is well-
documented in traumatic, neoplastic, and degenerative 
processes. However, BME is reported to represent a dis-
tinctive MRI finding in patients with RA, especially in the 
earlier phase of the disease(1). In most cases, it coexists 
with synovitis. However, in some cases, BME may precede 
synovitis or it may be the only feature of the disease. This 
suggests a potential role of MRI in the diagnosis of early 
stages of the disease, for instance in patients with no pa-
thologies seen on ultrasonography. BME was found in 39% 
of cases of early arthritis (<3 years duration) and in 68% of 
cases of established RA (>3 years duration)(1). 
BME is also an independent predictor of subsequent radio-
graphic progression in early RA, which means that it may 
precede erosion formation. The risk of erosion formation is 6 
times higher in areas in which BME had been noted earlier. 
In addition, MRI helps to detect more bone erosions in the 
wrist and hand in early RA than radiography and ultraso-
nography. Detection of bone erosions in the early phase of 
RA indicates irreversible joint damage and correlates with 
poor long-term radiographic and functional outcome(1). In 
early RA, MRI helps identify bone erosions in 45–72% of 
patients with disease of less than 6-month duration(1), com-
pared with 8–40% for radiography.
Follow-ups
Modern drug therapies reportedly decrease synovial prolifera-
tion and BME and prevent the development of bone erosions. 
MRI and sonography can qualitatively, semi-quantatively and 
quantitatively evaluate the synovium and bone marrow inflam-
mation, and identify treatment response as a reduction in syno-
vial volume and a decrease in the rate of synovial enhancement 
or area of inflamed bone marrow(2). Semi-quantative scoring 
methods of early rheumatoid arthritis features advancement 
(i.e. synovitis, bone erosions and bone edema) at the wrist and 
metacarpophalangeal joints have been developed and stan-
dardized for MRI by the OMERACT (Outcome Measures in 
Rheumatology Clinical Trials) and EULAR (European League 
Against Rheumatism) groups(2). However, they are rarely used 
in everyday clinical practice. 
One of the most exciting applications for MRI is monitoring 
of the response to treatment, including biologics, with MRI-
diagnosed synovitis and BME acting as imaging biomarkers 
for measuring patient responses to therapy. The first ran-
domized therapeutic trial using MRI as an outcome mea-
sure in early RA was published by Conaghan(3). MRI was 
used to follow synovitis and erosions in patients randomized 
to methotrexate +/– intraarticular corticosteroid(3). 
Fig. 7. MRI, bone marrow edema in the distal radius
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MRI of the spine in RA
The spine is a common target of rheumatoid arthritis, rank-
ing the third after the hands and feet(19). The proportion of 
patients who experience cervical spine involvement at some 
point of their disease ranges from 14% to 88%(19). Cervical 
spine involvement in patients with RA may lead to clinical 
manifestations varying from pain to neurologic deficits or 
even death from acute respiratory failure due to brainstem 
compression. These cervical spine lesions include: atlanto-
axial subluxation (AAS), subaxial subluxation (SSA), C1–C2 
arthritis, erosions and discitis(20,21) (Fig. 13).
MRI offers the most comprehensive evaluation of rheu-
matoid lesions in the spine. In RA patients, MRI is usu-
ally performed in order to assess the presence and activ-
ity of inflammation (pannus) and possible complications 
in the atlanto-axial, atlanto-occipital and subaxial areas, 
especially brainstem and/or spinal cord compression(20). 
The main abnormality at the upper CS is AAS (including 
anterior, vertical, lateral, rotatory and posterior) which 
is caused by the development of C1–C2 pannus and rup-
ture or luxation of the transverse ligament(20). At the lower 
CS, the main lesion is subaxial subluxation, and 10–50% 
of patients are asymptomatic(19). Other MRI features of 
RA are: dens and atlas erosions secondary to pannus 
destructive activity, brainstem compression, subarach-
noid space encroachment not only at the level C1/2 but 
also more distally, abnormal fat pad caudal to the clivus 
(present, displaced, reduced, absent), basilar invagina-
tion and subaxial spinal stenosis(21). Subarachnoid space 
encroachment was found to be associated with a 12-fold 
increased risk of neurological complications in a study by 
Reijnierse et al.(20) This enhancing tissue leads to stenosis, 
and presumably represents pannus and may lead to cord 
compression, with resultant irreversible cord atrophy(20). 
Dynamic flexion–extension MRI scanning in evaluating 
RA involvement of the cervical spine was found to diag-
Fig. 8.  Hand and wrist DCE-MRI: A. ROI covers the MCP 2 joint; B. white curve shows signal from 
the bone, and an orange one shows signal intensity (perfusion) from vessels of the inflamed 
synovium
Fig. 9.  Quantifying inflammation in the radiocarpal joint with the 
use of the vascularity index
Fig. 10.  Ultrasound, increased echogenicity and vascularization of 
the Kager’s fat pad
BA
13J Ultrason 2017; 17: 5–16
Rheumatoid arthritis: what do MRI and ultrasound show
nose subarachnoid encroachment in flexion that was not 
evident on neutral MRI(21). 
Remission
MRI and US may sensitively detect residual synovitis or 
BME that could persist even in the face of a clinical re-
sponse. This takes us back to the concept of imaging re-
mission, which may be the target of future therapy(22). It 
has been shown that many patients with RA who are in 
the stage of clinical remission continue to have persistent 
inflammatory processes at the cell level. In successfully 
treated cases, MRI and US will show fibrotic pannus which 
usually presents in end-stage RA and appears relatively 
hypovascular after iv administration of gadolinium-based 
contrast material or in Doppler studies. On T2-weighted 
MRI sequences, fibrous pannus with intermediate to low 
signal intensity can be distinguished from acute synovitis 
and joint fluid(1). 
Differential diagnosis
The diagnosis of early RA is often difficult, especially when 
laboratory tests do not indicate any specific entity. Hyper-
plastic and even slightly vascularized synovium can be seen 
in overuse injuries, osteoarthritis or soft tissue impinge-
ments. Also, other connective tissue diseases can be notori-
ously hard to differentiate with early RA. For example, in 
patients with psoriatic arthritis (PsA), MRI and ultrasound 
may show synovitis and tenosynovitis. In the later course, 
they may reveal erosions and periosteum irregularities. In 
addition, MRI can show a number of cervical spine pa-
thologies, resembling RA (active pannus, dens erosions, 
subluxations). Predilective areas include DIP joints and 
Fig. 12.  Ultrasound, longitudinal view of the radiocarpal and mid-
dcarpal joints: synovitis and erosions
Fig. 11.  MRI: A. coronal T1 TSE FS CM; B. axial T1 FS: metatarsophalangeal (MTP) 1 and 
MTP 5 synovitis and erosions
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one digit tendon sheath (sausage finger, dactylitis). BME 
in peripheral joints and in the subchondral part of entheses 
was found to be more extensive in PsA than in RA. Also, 
extracapsular inflammation is suspected to be specific for 
PsA. MRI may therefore show extensive signal intensity 
changes in the bone marrow and beyond joint capsule on 
STIR T2-weighted, fat-suppressed T2-weighted, or fat-sup-
pressed gadolinium-enhanced T1-weighted sequences(2). 
The latest data, however, show that even osteoarthritis may 
manifest with extensive BME and extracapsular inflamma-
tion on MRI(23). 
In patients with systemic lupus erythematosus, MRI may 
show abnormalities similar to those of patients with early 
RA (e.g., synovitis, tenosynovitis and bone erosions), and it 
might be impossible to differentiate patients with early RA 
Fig. 13.  Cervical spine: A. CT and MRI; B. sagittal T1-weighted image; C. sagittal T2- weighted image; D. axial T2-weighted image: dens 
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from those with systemic lupus erythematosus on MRI(2). 
We also observe fibrotic degeneration of tendons, involv-
ing the intramuscular part of tendons, which may lead to 
a tear, and seems specific for lupus. Such changes are very-
well seen in ultrasound. 
In 2014, Stomp et al.(24) conducted the first study to deter-
mine whether patients who are clinically classified with 
RA differ in MRI features from patients with other diseas-
es. Although patients with RA had higher scores of MRI 
inflammation than patients without RA and ACPA-positive 
patients had more BME than ACPA-negative, the severity 
of MRI inflammation assessed according to RAMRIS did 
not accurately differentiate patients with RA from other 
early arthritis patients. Because BME is a predictor of 
progression of joint destruction, this observation is in line 
with ACPA-positive RA being a more severe disease. 
Summary
MRI and ultrasound enable early diagnosis, follow-up, 
treatment and postinflammatory joint damage assess-
ment of synovial joints in patients with RA. MRI addition-
ally shows bone marrow inflammation and axial spine 
involvement. 
The spectrum of features seen on MRI and ultrasound 
corresponds well with histopathological stages of RA pro-
gression. 
Ultrasound is a quick and inexpensive way to detect syno-
vitis, tenosynovitis, tendon tears and bursitis. However, it 
is operator-dependent and also depends on the quality of 
a US machine. MRI allows a more global approach to all 
joints, both small and large, and the spine. It is more sensi-
tive and more specific that ultrasound. However, stage 1–2 
tendon tears are much better appreciated on ultrasound. 
Also, for maximal sensitivity, accurate scoring and sensi-
tive evaluation of changes over time, T1w sequences with 
contrast injection are mandatory. Unenhanced MRI using 
STIR sequences is only moderately reliable for assess-
ing synovitis and tenosynovitis. Contrast injection, field 
strength, and coil type influence MRI scan assessment, and 
should be considered before performing MRI in clinical 
trials and practice(4).
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